Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 27 cancer therapeutics PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
cancer therapeutics PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 27 cancer therapeutics PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Mining the Hippo signalling pathway for novel anti-cancer therapeutics
Candidates are invited to join the Kadri Lab where our research focuses on developing innovative chemical approaches for the discovery of novel therapeutics to address unmet global health needs. Read more
Cancer: Repurposing drugs as new treatments for breast cancer
Breast cancer (BC) is the most common cancer, with over 1 million new cases diagnosed worldwide each year. For some types of BC, hormonal treatments have been very effective but one particular BC subtype, triple negative breast cancer (TNBC), is highly aggressive and lacks a targeted therapy. Read more
Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer
Research Group:
Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more
Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
Research Group:
Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more
Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.
Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more
Artificial Intelligence with Human In The Loop for Automated Medical Image Contouring in Precision Oncology
Positron Emission Tomography (PET) yields quantitative images of regional in-vivo biology and biochemistry in the form of radioactive uptake, whilst Computed Tomography (CT) provides detailed anatomical images of anatomy. Read more
Development of exosome nano-therapeutics for cancer treatment
Exosomes are naturally occurring vesicles 50-100 nm in size that facilitate effective cell-to-cell communication. In tumours, cancer and stromal cell populations secrete large number of these exosomes to promote further tumour growth. Read more
Investigating the clinical and molecular significance of the microbiome in breast cancer
Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more
Developing new treatment combinations to target dormant cancer cells in myeloma
Multiple myeloma is the second most common blood cancer and remains essentially incurable. Chemotherapy is effective at reducing tumour and extends survival, but it never fully eradicates disease, so patients face inevitable relapse. Read more
Neurodegeneration-associated protein TAU: Novel regulation during the DNA damage response and links to p53.
Tau is a protein that regulates microtubule stability and dynamics and is involved in neurodegenerative diseases such as Alzheimer’s Disease - which is the most prevalent form of Dementia. Read more
Microneedle delivery systems for next-generation antibody therapeutics
Microneedle arrays are minimally-invasive devices that painlessly, and without drawing blood, penetrate the skin’s stratum corneum barrier. Read more
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics.
Overview. A hybrid class of nanoparticles, aimed at combining the advantages of both polymeric nanoparticles and liposomes, has received attention in recent years. Read more
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics.
Overview. A hybrid class of nanoparticles, aimed at combining the advantages of both polymeric nanoparticles and liposomes, has received attention in recent years. Read more
PhD opportunities in Non-Coding RNA and Cancer research.
PhD opportunity in Non-Coding RNA and Cancer research. Are you an ambitious MSc or PhD student seeking a challenge at the forefront of genomics, computational biology and RNA therapeutics?. Read more
Interdisciplinary Doctoral Training Hub in Precision Oncology at Cardiff University
These 3.5-year studentships provide funding for fees and stipend at the rate set by the UK Research Councils, as well as other research training and support costs, and are available to UK, EU and International students. Read more
- 1
- 2